首页> 外文OA文献 >Functional Pentameric Formation via Coexpression of the Escherichia coli Heat-Labile Enterotoxin B Subunit and Its Fusion Protein Subunit with a Neutralizing Epitope of ApxIIA Exotoxin Improves the Mucosal Immunogenicity and Protection against Challenge by Actinobacillus pleuropneumoniae▿
【2h】

Functional Pentameric Formation via Coexpression of the Escherichia coli Heat-Labile Enterotoxin B Subunit and Its Fusion Protein Subunit with a Neutralizing Epitope of ApxIIA Exotoxin Improves the Mucosal Immunogenicity and Protection against Challenge by Actinobacillus pleuropneumoniae▿

机译:通过共表达大肠杆菌不耐热肠毒素B亚基及其融合蛋白亚基与ApxIIA外毒素的中和表位而形成功能五聚体,可提高粘膜免疫原性并抵抗胸膜肺炎放线杆菌的攻击。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A coexpression strategy in Saccharomyces cerevisiae using episomal and integrative vectors for the Escherichia coli heat-labile enterotoxin B subunit (LTB) and a fusion protein of an ApxIIA toxin epitope produced by Actinobacillus pleuropneumoniae coupled to LTB, respectively, was adapted for the hetero-oligomerization of LTB and the LTB fusion construct. Enzyme-linked immunosorbent assay (ELISA) with GM1 ganglioside indicated that the LTB fusion construct, along with LTB, was oligomerized to make the functional heteropentameric form, which can bind to receptors on the mucosal epithelium. The antigen-specific antibody titer of mice orally administered antigen was increased when using recombinant yeast coexpressing the pentameric form instead of recombinant yeast expressing either the LTB fusion form or antigen alone. Better protection against challenge infection with A. pleuropneumoniae was also observed for coexpression in recombinant yeast compared with others. The present study clearly indicated that the coexpression strategy enabled the LTB fusion construct to participate in the pentameric formation, resulting in an improved induction of systemic and mucosal immune responses.
机译:使用大肠杆菌热不稳定肠毒素B亚基(LTB)的附加型和整合型载体以及胸膜肺炎放线杆菌与LTB偶联产生的ApxIIA毒素表位的融合蛋白,在啤酒酵母中共表达策略适用于异源寡聚化LTB和LTB融合构建体的构建。带有GM1神经节苷脂的酶联免疫吸附试验(ELISA)表明,LTB融合构建体与LTB一起被寡聚化,形成了功能性杂五聚体形式,可以与粘膜上皮受体结合。当使用共表达五聚体形式的重组酵母代替表达LTB融合形式或抗原的重组酵母时,口服抗原的小鼠的抗原特异性抗体效价增加。与其他菌株相比,重组酵母中的共表达也观察到更好的针对胸膜肺炎链球菌感染的保护作用。本研究清楚地表明,共表达策略使LTB融合构建体能够参与五聚体形成,从而改善了对全身和粘膜免疫应答的诱导。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号